Teehan Brendan bought PCRX
December 31, 2025 · Form 4 insider transaction
Teehan Brendan bought 402 shares of Pacira BioSciences, Inc. at $10.76 per share, a transaction worth $4.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
402
Price
$10.76
Total value
$4.3K
InsiderTeehan Brendan
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJanuary 6, 2026
Shares owned after54,402
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.